These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 27169538)

  • 1. Infection with Acinetobacter baumannii in an intensive care unit in the Western part of Romania.
    Lăzureanu V; Poroșnicu M; Gândac C; Moisil T; Bădițoiu L; Laza R; Musta V; Crișan A; Marinescu AR
    BMC Infect Dis; 2016 Mar; 16 Suppl 1(Suppl 1):95. PubMed ID: 27169538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic consumption versus the prevalence of multidrug-resistant Acinetobacter baumannii and Clostridium difficile infections at an ICU from 2014-2015.
    Ziółkowski G; Pawłowska I; Krawczyk L; Wojkowska-Mach J
    J Infect Public Health; 2018; 11(5):626-630. PubMed ID: 29548877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: antimicrobial and organizational strategies.
    Consales G; Gramigni E; Zamidei L; Bettocchi D; De Gaudio AR
    J Crit Care; 2011 Oct; 26(5):453-459. PubMed ID: 21439763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU].
    Ma MY; Xu J; Yu N; Huang GM
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):686-9. PubMed ID: 24225215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
    Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
    Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genetic relationship of Acinetobacter Baumannii isolates.
    Trajkovska-Dokic E; Kotevska V; Kaftandzieva A; Jankoska G; Mircevska G; Petrovska M; Panovski N
    Prilozi; 2011; 32(2):157-68. PubMed ID: 22286620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran.
    Safari M; Saidijam M; Bahador A; Jafari R; Alikhani MY
    J Res Health Sci; 2013 Sep; 13(2):162-7. PubMed ID: 24077474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
    Longo B; Pantosti A; Luzzi I; Tarasi A; Di Sora F; Gallo S; Placanica P; Monaco M; Dionisi AM; Volpe I; Montella F; Cassone A; Rezza G
    Ann Ist Super Sanita; 2007; 43(1):83-8. PubMed ID: 17536158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinetobacter baumannii nosocomial infections.
    Sieniawski K; Kaczka K; Rucińska M; Gagis L; Pomorski L
    Pol Przegl Chir; 2013 Sep; 85(9):483-90. PubMed ID: 24133105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
    Romanelli RM; Jesus LA; Clemente WT; Lima SS; Rezende EM; Coutinho RL; Moreira RL; Neves FA; Brás Nde J
    Braz J Infect Dis; 2009 Oct; 13(5):341-7. PubMed ID: 20428632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
    Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
    BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak.
    Metan G; Zarakolu P; Otlu B; Tekin İ; Aytaç H; Bölek EÇ; Metin BC; Arsava EM; Ünal S
    J Infect Public Health; 2020 Apr; 13(4):564-570. PubMed ID: 31672426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
    Dizbay M; Tunccan OG; Sezer BE; Hizel K
    Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.